HUMA
Humacyte Inc
0.5573$
-2.0%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | 100.0% | – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | 31.3% | – | – | – | 50.0% | 382.8% | 688.7% | 282.2% | 2,327.6% | 411.7% | 303.2% | 766.8% | |
| – | -31.3% | – | – | – | 50.0% | -282.8% | -588.7% | -182.2% | -2,227.6% | -311.7% | -203.2% | -666.8% | |
| – | 187.0% | – | – | – | 285.8% | 2,982.2% | 7,311.0% | 2,293.9% | 3,127.4% | 3,931.7% | 4,469.0% | 3,276.0% | |
| – | 55.6% | – | – | – | 102.8% | 1,573.7% | 2,594.4% | 1,010.6% | 4,932.5% | 1,602.0% | 1,977.1% | 2,197.2% | |
| – | 211.3% | – | – | – | 438.6% | 4,201.5% | 9,287.4% | 3,056.8% | 4,375.4% | 5,533.7% | 6,446.1% | 4,574.0% | |
| – | -242.7% | – | – | – | -388.6% | -4,484.3% | -9,876.1% | -3,239.0% | -6,603.0% | -5,845.5% | -6,649.3% | -5,240.8% | |
| – | 16.0% | – | – | – | 34.7% | 580.3% | 845.5% | 346.9% | 662.3% | 458.8% | 571.7% | 485.5% | |
| – | -232.7% | – | – | – | -289.7% | 7,570.4% | -12,511.0% | -2,325.4% | -5,311.3% | -3,559.4% | -9,064.5% | -4,560.8% | |
| – | -260.0% | – | – | – | -24.2% | – | – | – | – | – | – | – | |
| – | -232.7% | – | – | – | -289.7% | 7,570.4% | -12,511.0% | -2,325.4% | -5,311.3% | -3,559.4% | -9,064.5% | -4,560.8% | |
| – | -185.4% | – | – | – | -230.0% | 8,505.0% | -11,047.5% | -1,730.8% | -4,266.2% | -2,739.0% | -8,163.5% | -3,755.7% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.